Hypoxic damage to pancreatic beta cells - The hidden link between sleep apnea and diabetes

Medical Hypotheses

Volumn 77, Issue 5, 2011, Pages 930-934

  Pallayova, Maria ^a   Lazurova, Ivica ^a   Donic, Viliam ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

PROINSULIN;

ADRENERGIC SYSTEM; ARTICLE; CATALYSIS; CELL FUNCTION; DIABETOGENESIS; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GLUCOSE METABOLISM; HUMAN; HYPOXEMIA; HYPOXIA; INFLAMMATION; INSULIN RELEASE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PREVALENCE; SLEEP APNEA SYNDROME; STRESS;

CELL HYPOXIA; DIABETES MELLITUS, TYPE 2; HOMEOSTASIS; HUMANS; INSULIN; ISLETS OF LANGERHANS; MODELS, THEORETICAL; SLEEP APNEA SYNDROMES;

EID: 80053964782     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.08.016     Document Type: Article

References (54)

1. Pallayova M., Steele K.E., Magnuson T.H., et al. Sleep apnea predicts distinct alterations in glucose homeostasis, biomarkers in obese adults with normal, impaired glucose metabolism. Cardiovasc Diabetol 2010, 9:83.
2. Fonseca V.A. Defining and characterizing the progression of type 2 diabetes. Diab Care 2009, 32:S151-S156.
3. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance and hypercytokinemia. J Clin Endocrinol Metab 2000, 85:1151-1158.
4. Ip M.S., Lam B., Ng M.M., et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002, 165:670-676.
5. Punjabi N.M., Ahmed M.M., Polotsky V.Y., Beamer B.A., O'Donnell C.P. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 2003, 136:167-178.
6. Punjabi N.M., Shahar E., Redline S., Gottlieb D.J., Givelber R., Resnick H.E. Sleep Heart Health Study Investigators. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004, 160:521-530.
7. Punjabi N.M., Beamer B.A. Alterations in glucose disposal in sleep-disordered breathing. Am J Respir Crit Care Med 2009, 179:235-240.
8. Pallayova M., Donic V., Tomori Z. Beneficial effects of severe sleep apnea therapy on nocturnal glucose control in persons with type 2 diabetes mellitus. Diab Res Clin Pract 2008, 81:e8-e11.
9. Somers V.K., Mark A.L., Zavala D.C., et al. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 1989, 67:2101-2106.
10. Smith M.L., Niedermaier O.N., Hardy S.M., et al. Role of hypoxemia in sleep apnea-induced sympathoexcitation. J Auton Nerv Syst 1996, 56:184-190.
11. Xie A., Skatrud J.B., Puleo D.S., et al. Exposure to hypoxia produces long-lasting sympathetic activation in humans. J Appl Physiol 2001, 91:1555-1562.
12. Narkiewicz K., Somers V.K. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 2003, 177:385-390.
13. Oltmanns K.M., Gehring H., Rudolf S., et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 2004, 169:1231-1237.
14. Louis M., Punjabi N.M. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol 2009, 106:1538-1544.
15. Dawson A., Abel S.L., Loving R.T., et al. CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med 2008, 4:538-542.
16. Irminger J.C., Meyer K., Halban P. Proinsulin processing in the rat insulinoma cell line INS after overexpression of the endoproteases PC2 or PC3 by recombinant adenovirus. Biochem J 1996, 320:11-15.
17. Steiner D.F., Bell G.I., Tager H.S. Endocrinology 1995, 1296-1328. Saunders, Philadelphia, PA. L. DeGroot (Ed.).
18. Davidson H.W., Rhodes C.J., Hutton J.C. Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct endopeptidases. Nature 1988, 333:93-96.
19. Steiner D.F. The proprotein convertases. Curr Opin Chem Biol 1998, 2:31-39.
20. Goodge K.A., Hutton J.C. Translational regulation of proinsulin biosynthesis and proinsulin conversion in the pancreatic β-cell. Semin Cell Dev Biol 2000, 11:235.
21. Cherniack N.S. Oxygen sensing: applications in humans. J Appl Physiol 2004, 96:352-358.
22. Buckler K.J. Background leak K+-currents and oxygen sensing in carotid body type-I cells. Respir Physiol 1999, 115:179-187.
23. Donnelly D.F. K+ currents of glomus cells and chemosensory functions of carotid body. Respir Physiol 1999, 115:151-160.
24. Duchen M.R. Contributions of mitochondria to animal physiology: from homeostatic sensor to calcium signalling and cell death. J Physiol (Lond) 1999, 516:1-17.
25. Lopez-Barneo J., Pardal R., Montoro R.J., Smani T., Garcia-Hirschfeld J., Urena J. K+ and Ca2+ channel activity and cytosolic [Ca2+] in oxygen-sensing tissues. Respir Physiol 1999, 115:215-228.
26. Pallayova M., Steele K.E., Magnuson T.H., et al. Sleep apnea determines soluble TNF-α receptor 2 response to massive weight loss. Obes Surg 2011, [Epub ahead of print].
27. Ammit A.J., Lazaar A.L., Irani C., et al. Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. Am J Respir Cell Mol Biol 2002, 26:465-474.
28. Rosa Neto J.C., Lira F.S., Venancio D.P., et al. Sleep deprivation affects inflammatory marker expression in adipose tissue. Lipids Health Dis 2010, 9:125.
29. Abdul-Ghani M.A., DeFronzo R.A. Pathophysiology of prediabetes. Curr Diab Rep 2009, 9:193-199.
30. Diagnosis and classification of diabetes mellitus. Diab Care 2005, 28:S37-S42. American Diabetes Association.
31. Kahn C.R., Weir G.C., King G.L., Jacobson A.M., Moses A.C., Smith R.J. Joslin's Diabetes Mellitus. Selected Chapters from the Fourteenth Edition 2005, Lippincott Williams & Wilkins, Joslin Diabetes Center, Boston, MA, p. 89-99.
32. Temple R.C., Luzio S.D., Schneider A.E., Sobey W.J., Hales C.N. Insulin deficiency in noninsulin-dependent diabetes. Lancet 1989, 1:293-295.
33. Sandler S., Bendtzen K., Eizirik D.L., Welsh M. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro. Endocrinology 1990, 126:1288-1294.
34. Tsigos C., Papanicolaou D.A., Kyrou I., Defensor R., Mitsiadis C.S., Chrousos G.P. Dosedependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 1997, 82:4167-4170.
35. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
36. Grunstein R.R., Handelsman D.J., Lawrence S.J., Blackwell C., Caterson I.D., Sullivan C.E. Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. J Clin Endocrinol Metab 1989, 68:352-358.
37. Rapoport D.M., Rothenberg S.A., Hollander C.S., Goldring R.M. Obstructive sleep apnea (OSAS) alters ultradian rhythm of ACTH secretion. Am Rev Respir Dis 1989, 139:A80.
38. Cahan C., Arafah B., Decker M.J., Arnold J.L., Strohl K.P. Adrenal steroids in sleep apnea before and after nCPAP treatment. Am Rev Respir Dis 1991, 143:A382.
39. Cooper B.G., White J.E., Ashworth L.A., Alberti K.G., Gibson G.J. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 1995, 18:172-179.
40. Entzian P., Linnemann K., Schlaak M., Zabel P. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med 1996, 153:1080-1086.
41. Bratel T., Wennlund A., Carlstrom K. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med 1999, 93:1-7.
42. Meston N., Davies R.J., Mullins R., Jenkinson C., Wass J.A., Stradling J.R. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. J Intern Med 2003, 254:447-454.
43. Vgontzas A.N., Pejovic S., Zoumakis E., et al. Hypothalamicpituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. J Clin Endocrinol Metab 2007, 92:4199-4207.
44. Dadoun F., Darmon P., Achard V., et al. Effect of sleep apnoea syndrome on the circadian profile of cortisol in obese men. Am J Physiol Endocrinol Metab 2007, 293:E466-E474.
45. Schmoller A., Eberhardt F., Jauch-Chara K., et al. Continuous positive airway pressure therapy decreases evening cortisol concentrations in patients with severe obstructive sleep apnea. Metabolism 2009, 58:848-853.
46. Henley D.E., Russell G.M., Douthwaite J.A., et al. Hypothalamic-pituitary-adrenal axis activation in obstructive sleep apnea: the effect of continuous positive airway pressure therapy. J Clin Endocrinol Metab 2009, 94:4234-4242.
47. Zhou A., Bloomquist B., Mains R. The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. J Biol Chem 1993, 268:1763-1769.
48. Friedman T., Loh Y., Birch N. In vitro processing of proopiomelanocortin by recombinant PC1 (SPC3). Endocrinology 1994, 135:854-862.
49. Harbuz M.S., Lightman S.L. Stress and the hypothalamo-pituitary-adrenal axis: acute, chronic and immunological activation. J Endocrinol 1992, 134:327-339.
50. Lightman S.L. The neuroendocrinology of stress: a never ending story. J Neuroendocrinol 2008, 20:880-884.
51. Gianotti L., Pivetti S., Lanfranco F., et al. Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome. J Clin Endocrinol Metab 2002, 87:5052-5057.
52. Saini J., Krieger J., Brandenberger G., Wittersheim G., Simon C., Follenius M. Continuous positive airway pressure treatment. Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm Metab Res 1993, 25:375-381.
53. Van Cauter E., Caufriez A., Kerkhofs M., Van Onderbergen A., Thorner M.O., Copinschi G. Sleep, awakenings and insulin-like growth factor I modulate the growth hormone secretory response to growth hormone-releasing hormone. J Clin Endocrinol Metab 1992, 74:1451-1459.
54. Spath-Schwalbe E., Hundenbom C., Kern W., Fehm H., Born J. Nocturnal wakefulness inhibits growth hormone (GH)-releasing hormone-induced GH secretion. J Clin Endocrinol Metab 1995, 80:214-219.